Drug regulators and ethics: which GCP issues are also ethical issues?

Area of Science:

• Clinical Research Ethics
• Regulatory Science
• Bioethics

Background:

• Good Clinical Practice (GCP) in the European Union (EU) is intended to provide an ethical mandate for regulators.
• The precise content and scope of this ethical mandate within GCP regulations remain unclear.

Purpose of the Study:

• To identify the ethical imperatives underpinning EU Good Clinical Practice (GCP) regulations.
• To analyze the alignment between GCP regulations and established ethical principles.
• To propose improvements for future ethical guidelines and regulatory frameworks.

Main Methods:

• Comparative analysis of EU GCP regulations and core ethical imperatives.
• Identification of ethical principles directly reflected in GCP.
• Examination of regulations that are ethical but not directly linked to imperatives, or are stricter than imperatives.

Main Results:

• The ethical mandate within GCP encompasses principles, benefit-risk assessment, scientific validity, results publication, informed consent, participant respect, and special populations.
• Some regulations were found to be ethical but not directly pairable to a specific imperative.
• Instances where regulations exceeded ethical imperatives were also identified.

Conclusions:

• Closer collaboration between ethics committees and regulators is recommended to ensure future ethics guidelines encompass all ethically relevant regulations.
• Cooperation between GCP legislative bodies and ethics guideline-making bodies is crucial to resolve discordant areas and strengthen ethical oversight.